Trials / Unknown
UnknownNCT03495492
Chronic Lymphocytic Leukemia Responds to Dermal Chelation
Dermal Chelation Lowers White Blood Cell Count in Chronic Lymphocytic Leukemia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Optimum Health, Natural Healthcare Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte counts after performing dermal chelation and administering nutritional therapy
Detailed description
The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of these participants will be followed after serial dermal chelations and nutritional therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dermal Chelation | Dermal chelation with Aqua DetoxTM system for one or more hours one or more times each week. |
| DIETARY_SUPPLEMENT | Nutritional Therapy | Vitamins and minerals that will be taken one or more times a day. |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2019-03-01
- Completion
- 2019-03-01
- First posted
- 2018-04-12
- Last updated
- 2018-04-12
Source: ClinicalTrials.gov record NCT03495492. Inclusion in this directory is not an endorsement.